Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 28;79(8):880–890. doi: 10.1093/jnen/nlaa051

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 American Association of Neuropathologists, Inc. All rights reserved.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

PMC Copyright notice

FIGURE 4. — Kaplan-Meier curves showing overall survival of PXAs in our cohort. (A) Overall survival curve based on presence or absence of anaplasia. In our cohort, the absence of anaplasia was not statistically significantly associated with overall survival (p = 0.18). (B) Overall survival curve based on BRAF V600E mutation. Decreased overall survival was observed for subjects with tumors lacking the BRAF V600E mutation (p = 0.02). (C) Overall survival curve based on presence or absence of Trisomy 7. Trisomy 7 was not shown to be associated with overall survival (p = 0.67). (D) Overall survival based on CDKN2A/B deletion. CDKN2A/B homozygous deletion was not shown to be associated with overall survival (p = 0.74) compared with hemizygous deletion.